Cargando…
Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent
BACKGROUND: Onconase represents a new class of RNA-damaging drugs. Mechanistically, Onconase is thought to internalize, where it degrades intracellular RNAs such as tRNA and double-stranded RNA, and thereby suppresses protein synthesis. However, there may be additional or alternative mechanism(s) of...
Autores principales: | Altomare, Deborah A, Rybak, Susanna M, Pei, Jianming, Maizel, Jacob V, Cheung, Mitchell, Testa, Joseph R, Shogen, Kuslima |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829496/ https://www.ncbi.nlm.nih.gov/pubmed/20137089 http://dx.doi.org/10.1186/1471-2407-10-34 |
Ejemplares similares
-
Crystal structure of Onconase at 1.1 Å resolution – insights into substrate binding and collective motion
por: Holloway, Daniel E, et al.
Publicado: (2011) -
Onconase Mediated NFKβ Down-Regulation in Malignant Pleural Mesothelioma
por: Goparaju, Chandra M., et al.
Publicado: (2011) -
microRNA-494 and ATF3 the targets of onconase(?)
por: Darzynkiewicz, Zbigniew
Publicado: (2016) -
Chlorotoxin-conjugated onconase as a potential anti-glioma drug
por: WANG, XIAOMIN, et al.
Publicado: (2015) -
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase
por: Vert, Anna, et al.
Publicado: (2016)